About ITI
Scientific Advisory Board

Paul Greengard, Ph.D., Founder and Chairman of the Scientific Advisory Board

Paul Greengard received his Ph.D. in biophysics from Johns Hopkins University in 1953. After postgraduate work in England, he served for nine years as director of biochemical research at the Geigy Research Laboratories. In 1968, he was appointed Professor of Pharmacology at Yale University. In 1983 he became a professor at the Rockefeller University, where he founded the Laboratory of Molecular and Cellular Neuroscience.

Dr. Greengard is a pioneer in the field of neuronal signal transduction and his seminal discoveries over the years have provided a framework by which to understand the complexity of how neurotransmitters function in the brain. Dr. Greengard's many awards and honors include the CIBA-Geigy Drew Award in Biomedical Research (1979), the New York Academy of Sciences Award in Biological and Medical Sciences (1980), the Andrew D. White Professorship-at-Large of Cornell University (1981-87), the Pfizer Biomedical Research Award (1987), the Ralph W. Gerard Prize in Neuroscience, Society for Neuroscience (1994), the Charles A. Dana Award for Pioneering Achievements in Health (1997), and the Nobel Prize in Physiology or Medicine (2000). Dr. Greengard has also been a consultant to major pharmaceutical companies and a member of the scientific advisory boards of numerous biotechnology companies including Sugen and Aventis (now Sanofi).

Brian T. Chait, Ph.D., Camille and Henry Dreyfus Professor, the Rockefeller University.

Richard Huganir, Ph.D., Professor of Neuroscience, The Johns Hopkins University.

Richard Lerner, M.D., President, Scripps Research Institute.

Angus Nairn, Ph.D., Professor of Psychiatry, Yale University.

Eric Nestler, M.D., Ph.D., Lou and Ellen McGinley Distinguished Professor and Chairman of the Department of Psychiatry, University of Texas Southwestern Medical Center.

Richard H. Scheller, Ph.D., Senior Vice President, Research, Genentech.

Peter G. Schultz, Ph.D., Professor, The Scripps Research Institute and Director of the Genomics Institute of the Novartis Research Foundation.